Encapsulating sclerosingperitonitis : two Rare observations and literature review.

##plugins.themes.academic_pro.article.sidebar##

Published Jun 18, 2018
Download
pdf
Vol. 96 No. 1 (2018): Issue Jan 2018

##plugins.themes.academic_pro.article.main##

Houcine Maghrebi
Amine Makni
Rami Rhaeim
Alia Zehani
Anis Haddad
Amine Daghfous
Wael Rebai
Mohamed Jouini
Montasser Kacem
Zoubeir Ben Safta

Abstract

Sclerosing encapsulating peritonitis (SEP) is a rare and little known pathological entity. It is a chronic fibro-inflammatory disease of the peritoneum, resulting in the formation of a thick fibrous membrane, which engages partially or totally the abdominal organs. Clinical and radiological signs make the diagnosis difficult to establish preoperatively. We present two original observations of SEP illustrating different clinical presentations, diagnostic and therapeutic means. His diagnosis requires a peritoneal biopsy. The treatment is not completely established. Surgical treatment is difficult, involving viscerolysis and multiple incisions of the fibrous membrane. Despite the current progress in therapeutic management, the prognosis remains pejorative, with significant mortality.

Keywords:

Sclerosing encapsulating peritonitis, imaging, surgery

##plugins.themes.academic_pro.article.details##

References

  1. Da Luz MM, Barral SM, Barral CM, BecharaCde S, Lacerda-Filho A. Idiopathic encapsulating peritonitis: report of two cases. Surg Today. 2011 Dec;41(12):1644-8
  2. Minutolo V, Gagliano G, Angirillo G, Minutolo O, Morello A, Rinzivillo C. Intestinal obstruction due to idiopathic sclerosing encapsulating peritonitis. Clinical report and review of literature.G Chir.2008 ;29(4):173-6.
  3. Gandhi VC, Humayun HM, Ing TS, et al. Sclerotic thickening of peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern med. 1980;140:1201-3
  4. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. NDT. 1998;13:154-9.
  5. Rottembourg J, Issad B, Langlois P, et al. Loss of ultrafiltration and sclerosing encapsulating peritonitis during CAPD: evaluation of the potentiel risk factors. Adv CAPD. 1985;1:109-17
  6. Niaudet P, Berard E, Revillon Y, Lothon, M, Broyer M. Sclerosing encapsulating peritonitis in children. ContrNephrol. 1987;57:230-238.
  7. Sahoo SP, Gangopadhyay AN, Gupta DK, Gopal SC, Sharma SP, Dash RN. Abdominal cocoon in children: a report of four cases. J PediatrSurg.1996;31:987- 988.
  8. AlscherDm et Al. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients. Am J Kidney Dis. 2007 (49):452-61.
  9. Latus J et al. Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany. Nephrol. Dial. Transplant.2013;28, 1021-1030
  10. Xu P et Al. Idiopathic sclerosing encapsulating peritonitis (or abdom-inal cocoon): a report of 5 cases. World J Gastroenterol. 2007(26):3649 - 51.
  11. Aihara H et Al. Sclerosing encapsulating perito-nitis as delayed complication of continuous hyperthermic peritoneal perfusion: report of a case. Surg Today. 2003 (33): 232-236.
  12. Vlijm A, van Schuppen J, Lamers AB, Struijk DG, Krediet RT. Imaging in encapsulating peritoneal sclerosis. NDT Plus. 2011;4:281-4
  13. Gancer K et Al. Sclerosing encapsulating peritoni-tis: differential diagnosis to peritoneal encapsulation and abdominal cocoon. Néphrologie & Thérapeutique. 2011 (7): 162-171.
  14. Kawanishi H. Surgical and medical treatments of encapsulation peritoneal sclerosis. ContribNephrol. 2012;177:38-47
  15. Johnson DW et Al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int. 2010 (77):904- 912.
  16. Tagnaoutia M et Al. La sclérose péritonéale encapsulante : aspects actuels Néphrologie & Thérapeutique. 2009 (5): 122—133
  17. Kawanishi H, Kawaguchi Y. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. AJKD. 2004;44(4):729—37.